Valuation CStone Pharmaceuticals OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 22:21:14 10/07/2026 +03			5-day change	1st Jan Change
0.7100 ^USD	+19.43%		0.00%	-20.49%

07-20	Cstone Pharmaceuticals Announces Updated Clinical Data and Esmo 2026 Presentations for Cs2009 Trispecific Antibody	CI
06-26	CStone Pharma Taps Arrotex to Commercialize Sugemalimab in Australia, New Zealand	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	7,845	4,882	2,628	2,759	6,980	6,375	-	-
Change	-	-37.77%	-46.18%	4.99%	153.01%	-8.67%	-	-
Enterprise Value (EV) ¹	7,249	4,551	1,950	2,404	6,404	5,847	2,772	2,198
Change	-	-37.22%	-57.15%	23.28%	166.37%	-8.7%	-52.59%	-20.69%
P/E	-	-5.32x	-7.11x	-30.9x	-15.3x	-299x	5.95x	36.3x
PBR	6.63x	10.9x	5.7x	-	10.7x	-	-	-
PEG	-	-	0.1x	0.4x	-0x	3.1x	-0x	-0.4x
Capitalization / Revenue	32.2x	10.1x	5.67x	6.78x	25.9x	13.3x	3.72x	5.78x
EV / Revenue	29.7x	9.45x	4.2x	5.9x	23.8x	12.2x	1.62x	1.99x
EV / EBITDA	-3.99x	-5.1x	-3.33x	-25.9x	-16.5x	-14.3x	1.41x	3.03x
EV / EBIT	-3.96x	-4.99x	-3.22x	-22.7x	-14.8x	-15.3x	2.48x	12.4x
EV / FCF	-4.57x	-7.43x	-	-	-19.5x	2,923x	37.5x	31.4x
FCF Yield	-21.9%	-13.5%	-	-	-5.12%	0.03%	2.67%	3.18%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-0.77	-0.29	-0.07	-0.31	-0.0133	0.67	0.11
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	243.7	481.4	463.8	407.2	269.6	479.3	1,713	1,103
EBITDA ¹	-1,818	-892.9	-585.4	-92.72	-388.6	-409.6	1,962	724.4
EBIT ¹	-1,829	-912.1	-605.6	-106.1	-432.6	-383.2	1,118	177.6
Net income ¹	-1,920	-902.7	-367.2	-91.21	-437	-243.2	687.4	93.49
Net Debt ¹	-596.2	-331.1	-677.7	-354.7	-576.3	-528.2	-3,603	-4,177
Reference price ²	6.737	4.096	2.061	2.161	4.736	3.989	3.989	3.989
Nbr of stocks (in thousands)	1,164,452	1,192,099	1,275,317	1,276,503	1,473,942	1,598,209	-	-
Announcement Date	6/8/22 A	4/26/23 A	4/23/24 A	3/27/25 A	3/26/26 A	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	17.35x	3.71x	9.57x	0.59%	66.74B
UCB	26.36x	5.45x	16.03x	0.6%	53.32B
SAMSUNG BIOLOGICS CO.,LTD.	37.26x	12.6x	24.05x	-.--%	48.12B
CSL LIMITED	-42.39x	3.06x	9.03x	3.57%	38.25B
BIOGEN INC.	25.06x	3.49x	11.87x	-.--%	29.85B
INCYTE CORPORATION	56.96x	3.39x	25.31x	-.--%	23.51B
MODERNA, INC.	-6.24x	8.61x	-5.3x	-.--%	21.45B
INNOVENT BIOLOGICS, INC.	64.96x	6.38x	43.91x	-.--%	19.97B
SWEDISH ORPHAN BIOVITRUM AB	24.05x	5.15x	13.48x	-.--%	16.38B
Average	22.60x	5.76x	16.44x	0.53%	35.29B
Weighted average by Cap.	20.08x	5.80x	15.52x	0.65%